On Tuesday, Newell Rubbermaid Inc. (NYSE:NWL)’s shares declined -0.01% to $40.69.
Newell Rubbermaid (NWL) declared the declaration of a quarterly cash dividend of $0.19 per share. The dividend is payable September 15, 2015 to common stockholders of record at the close of business on August 31, 2015.
Newell Rubbermaid Inc. manufactures and markets consumer and commercial products worldwide. It operates through five segments: Writing, Home Solutions, Tools, Commercial Products, and Baby & Parenting. The Writing segment offers writing instruments, such as markers and highlighters, pens, and pencils; art products; fine writing instruments; and labeling solutions under the Sharpie, Paper Mate, Expo, Parker, Waterman, and Dymo Office brand names.
Lifelock Inc (NYSE:LOCK)’s shares showed no changed to $8.28.
LifeLock, Inc. (LOCK), an industry leader in identity theft protection, declared financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Financial Highlights:
- Revenue: Total revenue was $145.0 million for the second quarter of 2015, up 25% from $115.7 million for the second quarter of 2014. Consumer revenue was $138.3 million for the second quarter of 2015, up 27% from $109.3 million for the second quarter of 2014. Enterprise revenue was $6.6 million for the second quarter of 2015, up 4.0% from $6.4 million for the second quarter of 2014.
- Net Income: Net income was $0.5 million for the second quarter of 2015, contrast with a net loss of $1.5 million for the second quarter of 2014. Net income per diluted share was $0.01 for the second quarter of 2015 based on 100.3 million weighted-average shares outstanding, contrast with a net loss per diluted share of $0.02 for the second quarter of 2014 based on 92.5 million weighted-average shares outstanding.
- Adjusted Net Income*: Adjusted net income was $10.0 million for the second quarter of 2015, contrast with an adjusted net income of $4.6 million for the second quarter of 2014. Adjusted net income per diluted share was $0.10 for the second quarter of 2015 based on 100.3 million weighted-average shares outstanding, contrast with an adjusted net income per diluted share of $0.05 for the second quarter of 2014 based on 98.1 million weighted-average shares outstanding.
LifeLock, Inc. provides identity theft protection services for consumers; and consumer risk administration services for enterprises in the United States. It protects consumer subscribers through monitoring identity-related events, such as new account openings and credit-related applications; and enterprise customers through delivering on-demand identity risk, identity authentication, and credit information about consumers.
At the end of Tuesday ‘s trade, Houghton Mifflin Harcourt Co (NASDAQ:HMHC)‘s shares dipped -1.06% to $22.34.
Global learning company Houghton Mifflin Harcourt (HMH) has attained select eBook and technology assets of MeeGenius — an eBook subscription service for children aged up to eight years old. The acquisition marks the Company’s latest investment in high-quality digital content for parents and young learners and supports its ongoing planned focus on the direct-to-consumer market.
Accessible in both iOS and Android, the award winning MeeGenius app and subscription service offer mobile access to hundreds of classic children’s stories, MeeGenius originals, and content from authors around the world, improved with interactive digital features such as read-along word highlighting, audio playback, and engaging story narration.
Houghton Mifflin Harcourt Company provides education solutions for educational institutions and consumers worldwide. It delivers content, technology, and services to about 50 million students. The company operates in two segments, Education and Trade Publishing. The Education segment develops, publishes, and markets various comprehensive curriculum programs that focus on reading, literature and language arts, mathematics, science, world languages, and social studies for the pre-K-12 market; and comprehensive intervention solutions for assisting English language learners, in addition to products providing incremental instruction in a particular subject area.
Galena Biopharma Inc (NASDAQ:GALE), ended its Tuesday ‘s trading session shares showed no change, and closed at $1.58.
Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, stated its financial results for the quarter ended June 30, 2015 and offered a business update.
FINANCIAL HIGHLIGHTS AND GUIDANCE
Operating loss for the second quarter of 2015 was $11.3 million, counting $0.6 million in stock based compensation, contrast to an operating loss of $15.8 million, counting $1.5 million in stock-based compensation for the same period last year. Operating loss for the first half of 2015 was $22.4 million, counting $1.3 million in stock based compensation, contrast to an operating loss of $27.6 million, counting $3.2 million in stock-based compensation for the same period in 2014. The decrease in net operating loss year-over-year is primarily the result of the completion of enrollment in our Phase 3 PRESENT trial for NeuVax, in addition to the decrease in stock based compensation and professional fees associated with ongoing legal proceedings.
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. Its commercial products comprise Abstral, a sublingual tablet that is used for the administration of breakthrough pain in patients with cancer; and Zuplenz, an oral soluble film for use in the prevention of chemotherapy-induced, radiotherapy-induced, and post-operative nausea and vomiting.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
